So the current argument is "What is Advaxis worth if it's sold?" I've challenged the board before to do some math, and had been accused of putting the cart before the horse, even though this is what exactly is required in addressing such a question. It seems to me that some here are speculating not on facts, but rather on "What would I be happy with?" or in short, emotion. Or take full faith in some analysts estimate of what this company will be worth in 1 year or so. Some analyst paid to generate content who most likely doesn't give a rat's a** about accuracy. And said analyst is only giving a figure for what they think it will be worth in one year, not what the company might be worth if sold.
In a previous post I did some math on HER2 in breast cancer in the US, made a few assumptions, and come up with a figure. I estimated around 1B in annual sales in the US alone for breast cancer alone. Which translates to around 1B in annual profits, because it costs next to nothing to manufacture.
Let me do it again for Pediatric Osteosacoma, another HER2 related disease.
In the US there are 400 new cases a year. We know there are no good treatments for this. We also know the Advaxis is effective in dogs with the same disease, the best animal model around, so it's likely to be effective in humans as well. Since there are no other good treatments around, let's up the cost to 100K. 100K x 400 = 40M
OK, not an earth shattering number, but I use this as another example of what this board should be doing. Generating estimates based on facts and reasonable assumptions. Not emotion. Not impatients. I guarantee you if Lombardo et al are in the process of selling Advaxis this is exactly what they're doing. Would you have it any other way?
FBG, Bourbon - Would you have it any other way?? I challenge the both of you - pick a disease, pick a construct, make some assumptions on cost and market penetration, do some math, come up with a figure. The paragraph above took me less than 10 minutes research.
